{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:46:47Z","timestamp":1790790407712,"version":"4.1.0"},"reference-count":149,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.cyto.2015.02.002","type":"journal-article","created":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T05:25:06Z","timestamp":1431149106000},"page":"43-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":130,"title":["The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis"],"prefix":"10.1016","volume":"74","author":[{"given":"Sandra M.J.","family":"Paulissen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Piet","family":"van Hamburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Dankers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Lubberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2015.02.002_b0005","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(09)60008-8","article-title":"Rheumatoid arthritis","volume":"373","author":"Klareskog","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2015.02.002_b0010","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2015.02.002_b0015","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nri2804","article-title":"The changing face of rheumatoid arthritis: sustained remission for all?","volume":"10","author":"Isaacs","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.cyto.2015.02.002_b0020","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar2412","article-title":"T cells in rheumatoid arthritis","volume":"10","author":"Cope","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cyto.2015.02.002_b0025","doi-asserted-by":"crossref","DOI":"10.2174\/1381612820666140825122247","article-title":"Role of T lymphocytes in the development of rheumatoid arthritis. Implications for treatment","author":"Lubberts","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.cyto.2015.02.002_b0030","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1172\/JCI36389","article-title":"Evidence that cytokines play a role in rheumatoid arthritis","volume":"118","author":"Brennan","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2015.02.002_b0035","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","article-title":"Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium","volume":"42","author":"Chabaud","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2015.02.002_b0040","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM200103223441207","article-title":"Cytokine pathways and joint inflammation in rheumatoid arthritis","volume":"344","author":"Choy","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2015.02.002_b0045","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.21749","article-title":"Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort)","volume":"54","author":"Kirkham","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2015.02.002_b0050","doi-asserted-by":"crossref","DOI":"10.1186\/ar1733","article-title":"Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin","volume":"7","author":"Raza","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cyto.2015.02.002_b0055","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0060","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ni1467","article-title":"Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0065","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ni.1610","article-title":"The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat","volume":"9","author":"Manel","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.30093","article-title":"Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production","volume":"63","author":"van Hamburg","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2015.02.002_b0075","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/art.27622","article-title":"Role of Th17 cells in human autoimmune arthritis","volume":"62","author":"Leipe","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2015.02.002_b0080","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/art.23291","article-title":"Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers","volume":"58","author":"Nistala","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2015.02.002_b0085","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4049\/jimmunol.1300274","article-title":"Synovial fibroblasts directly induce Th17 pathogenicity via the cyclooxygenase\/prostaglandin E2 pathway, independent of IL-23","volume":"191","author":"Paulissen","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0090","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ni.1770","article-title":"Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells","volume":"10","author":"Trifari","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.20130301","article-title":"Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids","volume":"211","author":"Ramesh","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2015.02.002_b0100","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1002\/eji.201242648","article-title":"Distinctive features of classic and nonclassic (Th17 derived) human Th1 cells","volume":"42","author":"Maggi","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/imr.12035","article-title":"The Th17 family: flexibility follows function","volume":"252","author":"Basu","year":"2013","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cyto.2015.02.002_b0110","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","article-title":"T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines","volume":"183","author":"Fossiez","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2015.02.002_b0115","doi-asserted-by":"crossref","first-page":"14893","DOI":"10.1074\/jbc.272.23.14893","article-title":"Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC","volume":"272","author":"Baba","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2015.02.002_b0120","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4049\/jimmunol.162.1.186","article-title":"CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha","volume":"162","author":"Liao","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0125","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1084\/jem.20071397","article-title":"Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model","volume":"204","author":"Hirota","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2015.02.002_b0130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nature13279","article-title":"Focused specificity of intestinal TH17 cells towards commensal bacterial antigens","volume":"510","author":"Yang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2015.02.002_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2014.07.006","article-title":"Targeting Th17 cells in autoimmune diseases","author":"Yang","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.cyto.2015.02.002_b0140","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1084\/jem.20070663","article-title":"Phenotypic and functional features of human Th17 cells","volume":"204","author":"Annunziato","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2015.02.002_b0145","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17-producing helper T cells","volume":"8","author":"Wilson","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0150","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0155","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/1074-7613(95)90070-5","article-title":"Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor","volume":"3","author":"Yao","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2015.02.002_b0160","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.4049\/jimmunol.167.8.4137","article-title":"Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production","volume":"167","author":"Starnes","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0165","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni.1813","article-title":"Structural basis of receptor sharing by interleukin 17 cytokines","volume":"10","author":"Ely","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0170","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.4049\/jimmunol.0801967","article-title":"Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes","volume":"182","author":"Zrioual","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0175","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/ard.2010.143768","article-title":"Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes","volume":"70","author":"Hot","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2015.02.002_b0180","doi-asserted-by":"crossref","first-page":"13447","DOI":"10.1074\/jbc.M700499200","article-title":"Identification of an interleukin 17F\/17A heterodimer in activated human CD4+ T cells","volume":"282","author":"Wright","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2015.02.002_b0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd4176","article-title":"Therapeutic opportunities of the IL-22-IL-22R1 system","volume":"13","author":"Sabat","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cyto.2015.02.002_b0190","doi-asserted-by":"crossref","first-page":"31335","DOI":"10.1074\/jbc.M005304200","article-title":"Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R","volume":"275","author":"Xie","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2015.02.002_b0195","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ni.2025","article-title":"Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22","volume":"12","author":"Sonnenberg","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0200","doi-asserted-by":"crossref","first-page":"33343","DOI":"10.1074\/jbc.M405000200","article-title":"The T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chains","volume":"279","author":"Hor","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2015.02.002_b0205","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.cdd.4401189","article-title":"Tumor necrosis factor signaling","volume":"10","author":"Wajant","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.cyto.2015.02.002_b0210","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood-2009-04-216085","article-title":"Evidence for a cross-talk between human neutrophils and Th17 cells","volume":"115","author":"Pelletier","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.02.002_b0215","doi-asserted-by":"crossref","first-page":"241ra80","DOI":"10.1126\/scitranslmed.3008706","article-title":"IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells","volume":"6","author":"Noster","year":"2014","journal-title":"Sci Translat Med"},{"key":"10.1016\/j.cyto.2015.02.002_b0220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/CE.S39770","article-title":"Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis","volume":"9","author":"Di Franco","year":"2014","journal-title":"Core Evid"},{"key":"10.1016\/j.cyto.2015.02.002_b0225","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cytogfr.2009.02.004","article-title":"Interferon-gamma: a historical perspective","volume":"20","author":"Billiau","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cyto.2015.02.002_b0750","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jaci.2008.12.017","article-title":"Differentiation and functional analysis of human T(H)17 cells","volume":"123","author":"Burgler","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0235","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1767","article-title":"Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells","volume":"10","author":"Duhen","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0240","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4049\/jimmunol.180.1.122","article-title":"Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells","volume":"180","author":"Lim","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0245","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1084\/jem.20080397","article-title":"Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor","volume":"205","author":"Cosmi","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2015.02.002_b0250","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fimmu.2011.00036","article-title":"CD161-expressing human T cells","volume":"2","author":"Fergusson","year":"2011","journal-title":"Front Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0255","doi-asserted-by":"crossref","first-page":"7791","DOI":"10.4049\/jimmunol.175.12.7791","article-title":"Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor","volume":"175","author":"Aldemir","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0260","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood-2007-12-130773","article-title":"PILAR is a novel modulator of human T-cell expansion","volume":"112","author":"Huarte","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.02.002_b0265","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20082293","article-title":"Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2\/EP4 receptor signaling","volume":"206","author":"Boniface","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2015.02.002_b0270","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1172\/JCI72973","article-title":"Decreased RORC-dependent silencing of prostaglandin receptor EP2 induces autoimmune Th17 cells","volume":"124","author":"Kofler","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2015.02.002_b0275","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2015.02.002_b0280","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cell.2012.09.016","article-title":"A validated regulatory network for Th17 cell specification","volume":"151","author":"Ciofani","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2015.02.002_b0285","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.4049\/jimmunol.1302190","article-title":"Pharmacologic inhibition of RORgammat regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo","volume":"192","author":"Skepner","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0290","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.imlet.2012.09.007","article-title":"Key molecules in the differentiation and commitment program of T helper 17 (Th17) cells up-to-date","volume":"148","author":"Hemdan","year":"2012","journal-title":"Immunol Lett"},{"key":"10.1016\/j.cyto.2015.02.002_b0295","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","article-title":"Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies","volume":"181","author":"Maddur","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cyto.2015.02.002_b0300","doi-asserted-by":"crossref","first-page":"7423","DOI":"10.4049\/jimmunol.180.11.7423","article-title":"Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes","volume":"180","author":"Pene","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0305","doi-asserted-by":"crossref","first-page":"e1001395","DOI":"10.1371\/journal.pbio.1001395","article-title":"IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation","volume":"10","author":"Corvaisier","year":"2012","journal-title":"PLoS Biol"},{"key":"10.1016\/j.cyto.2015.02.002_b0310","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/ar2009","article-title":"Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritis","volume":"8","author":"Raza","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cyto.2015.02.002_b0315","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/annrheumdis-2011-200424","article-title":"TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation","volume":"71","author":"van Hamburg","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2015.02.002_b0320","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1136\/annrheumdis-2012-202373","article-title":"IL-17\/Th17 mediated synovial inflammation is IL-22 independent","volume":"72","author":"van Hamburg","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2015.02.002_b0325","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/art.24568","article-title":"Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis","volume":"60","author":"Shen","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2015.02.002_b0330","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/1756-185X.12099","article-title":"IL-22+ CD4+ T cells in patients with rheumatoid arthritis","volume":"16","author":"Zhao","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.cyto.2015.02.002_b0335","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/B978-0-12-394299-9.00002-3","article-title":"Autoimmune arthritis: the interface between the immune system and joints","volume":"115","author":"Komatsu","year":"2012","journal-title":"Adv Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0340","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.molmed.2010.07.004","article-title":"Rheumatoid arthritis progression mediated by activated synovial fibroblasts","volume":"16","author":"Neumann","year":"2010","journal-title":"Trends Mole Med"},{"key":"10.1016\/j.cyto.2015.02.002_b0345","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/ard.2010.132233","article-title":"IL-17A- versus IL-17F-induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in rheumatoid synoviocytes","volume":"70","author":"Hot","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2015.02.002_b0350","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/ar115","article-title":"Cell-cell interactions in synovitis. Interactions between T lymphocytes and synovial cells","volume":"2","author":"McInnes","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1016\/j.cyto.2015.02.002_b0355","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/art.10816","article-title":"Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy","volume":"48","author":"Miossec","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2015.02.002_b0360","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2353\/ajpath.2007.070004","article-title":"Molecular interactions between T cells and fibroblast-like synoviocytes: role of membrane tumor necrosis factor-alpha on cytokine-activated T cells","volume":"171","author":"Tran","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cyto.2015.02.002_b0365","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/art.20965","article-title":"Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine","volume":"52","author":"Ikeuchi","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2015.02.002_b0370","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.immuni.2008.07.018","article-title":"Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction","volume":"29","author":"Ogura","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2015.02.002_b0375","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2741\/1817","article-title":"Matrix metalloproteinases: role in arthritis","volume":"11","author":"Burrage","year":"2006","journal-title":"Frontiers Biosci J Virt Lib"},{"key":"10.1016\/j.cyto.2015.02.002_b0380","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/1529-0131(200201)46:1<31::AID-ART10029>3.0.CO;2-5","article-title":"Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis","volume":"46","author":"Brennan","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2015.02.002_b0385","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10067-005-1081-1","article-title":"IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes","volume":"25","author":"Ryu","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cyto.2015.02.002_b0390","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1002\/art.23653","article-title":"Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption","volume":"58","author":"Tunyogi-Csapo","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2015.02.002_b0395","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/1529-0131(200011)43:11<2523::AID-ANR20>3.0.CO;2-Z","article-title":"Expression of osteoclast differentiation factor in rheumatoid arthritis","volume":"43","author":"Shigeyama","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2015.02.002_b0400","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI5703","article-title":"IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis","volume":"103","author":"Kotake","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2015.02.002_b0405","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.4049\/jimmunol.1003370","article-title":"Th17 cells, not IL-17+ gammadelta T cells, drive arthritic bone destruction in mice and humans","volume":"186","author":"Pollinger","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0410","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/rheumatology\/kes304","article-title":"Targeting monocytes\/macrophages in the treatment of rheumatoid arthritis","volume":"52","author":"Davignon","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2015.02.002_b0415","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4049\/jimmunol.174.2.864","article-title":"Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines","volume":"174","author":"Ohata","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0420","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1172\/JCI25265","article-title":"BLyS and APRIL in rheumatoid arthritis","volume":"115","author":"Seyler","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2015.02.002_b0425","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.4049\/jimmunol.177.3.1941","article-title":"Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene","volume":"177","author":"Bosco","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0430","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/ar4325","article-title":"Role of neutrophils in systemic autoimmune diseases","volume":"15","author":"Kaplan","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cyto.2015.02.002_b0435","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrrheum.2014.80","article-title":"The multifactorial role of neutrophils in rheumatoid arthritis","volume":"10","author":"Wright","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.cyto.2015.02.002_b0440","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.4049\/jimmunol.171.12.6846","article-title":"Granulocyte-macrophage colony-stimulating factor is a chemoattractant cytokine for human neutrophils: involvement of the ribosomal p70 S6 kinase signaling pathway","volume":"171","author":"Gomez-Cambronero","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0445","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/rheumatology\/ker338","article-title":"Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy","volume":"51","author":"Wright","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2015.02.002_b0450","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/art.34391","article-title":"Bone marrow-derived and synovium-derived mesenchymal cells promote Th17 cell expansion and activation through caspase 1 activation: contribution to the chronicity of rheumatoid arthritis","volume":"64","author":"Eljaafari","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2015.02.002_b0455","doi-asserted-by":"crossref","first-page":"e100266","DOI":"10.1371\/journal.pone.0100266","article-title":"Toll-like receptors expressed by synovial fibroblasts perpetuate Th1 and th17 cell responses in rheumatoid arthritis","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2015.02.002_b0460","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/annrheumdis-2012-202444","article-title":"Hypoxia and hypoxia-inducible factor-1alpha provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis","volume":"73","author":"Hu","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2015.02.002_b0465","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1038\/emm.2013.39","article-title":"MRP8 promotes Th17 differentiation via upregulation of IL-6 production by fibroblast-like synoviocytes in rheumatoid arthritis","volume":"45","author":"Lee","year":"2013","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.cyto.2015.02.002_b0470","doi-asserted-by":"crossref","first-page":"e1001881","DOI":"10.1371\/journal.pbio.1001881","article-title":"Hypoxia-inducible factor-2alpha is an essential catabolic regulator of inflammatory rheumatoid arthritis","volume":"12","author":"Ryu","year":"2014","journal-title":"PLoS Biol"},{"key":"10.1016\/j.cyto.2015.02.002_b0475","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1073\/pnas.0808144106","article-title":"In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses","volume":"106","author":"Evans","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2015.02.002_b0480","doi-asserted-by":"crossref","first-page":"17034","DOI":"10.1073\/pnas.0708426104","article-title":"Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes","volume":"104","author":"Evans","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2015.02.002_b0485","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/art.33418","article-title":"The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population","volume":"64","author":"Rossol","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2015.02.002_b0490","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1182\/blood-2008-05-155408","article-title":"Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion","volume":"112","author":"Chizzolini","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.02.002_b0495","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20102516","article-title":"Cytokine signals through PI-3 kinase pathway modulate Th17 cytokine production by CCR6+ human memory T cells","volume":"208","author":"Wan","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2015.02.002_b0500","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.smim.2013.10.021","article-title":"Identity crisis of Th17 cells: many forms, many functions, many questions","volume":"25","author":"Sundrud","year":"2013","journal-title":"Semin Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0505","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000363502","article-title":"Th17 and non-classic Th1 cells in chronic inflammatory disorders: two sides of the same coin","volume":"164","author":"Cosmi","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0510","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/eji.201242741","article-title":"Human Th17 subsets","volume":"42","author":"Sallusto","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0515","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.immuni.2012.08.024","article-title":"Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria","volume":"37","author":"Basu","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2015.02.002_b0520","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s10753-013-9715-y","article-title":"Targeting interleukin-22 in psoriasis","volume":"37","author":"Hao","year":"2014","journal-title":"Inflammation"},{"key":"10.1016\/j.cyto.2015.02.002_b0525","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1136\/ard.2011.152074","article-title":"Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis","volume":"70","author":"Leipe","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2015.02.002_b0530","doi-asserted-by":"crossref","first-page":"14751","DOI":"10.1073\/pnas.1003852107","article-title":"Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment","volume":"107","author":"Nistala","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2015.02.002_b0535","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/art.30332","article-title":"Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis","volume":"63","author":"Cosmi","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2015.02.002_b0755","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keu171","article-title":"CD70-expressing CD4 T cells produce IFN-gamma and IL-17 in rheumatoid arthritis","author":"Park","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2015.02.002_b0545","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/cr.2009.138","article-title":"Heterogeneity and plasticity of T helper cells","volume":"20","author":"Zhu","year":"2010","journal-title":"Cell Res"},{"key":"10.1016\/j.cyto.2015.02.002_b0550","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.immuni.2008.12.009","article-title":"Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells","volume":"30","author":"Wei","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2015.02.002_b0555","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.immuni.2008.11.005","article-title":"Late developmental plasticity in the T helper 17 lineage","volume":"30","author":"Lee","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2015.02.002_b0560","doi-asserted-by":"crossref","first-page":"679","DOI":"10.4049\/jimmunol.1000366","article-title":"Human Th17 cells comprise heterogeneous subsets including IFN-gamma-producing cells with distinct properties from the Th1 lineage","volume":"185","author":"Boniface","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0565","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.smim.2013.10.009","article-title":"The plasticity of human Treg and Th17 cells and its role in autoimmunity","volume":"25","author":"Kleinewietfeld","year":"2013","journal-title":"Semin Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0570","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1182\/blood-2008-10-183251","article-title":"IL-17-producing human peripheral regulatory T cells retain suppressive function","volume":"113","author":"Beriou","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.02.002_b0575","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.02.002_b0580","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1073\/pnas.0900621106","article-title":"Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t","volume":"106","author":"Ayyoub","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2015.02.002_b0585","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1073\/pnas.0900408106","article-title":"Identification of IL-17-producing FOXP3+ regulatory T cells in humans","volume":"106","author":"Voo","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2015.02.002_b0590","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/jid.2011.139","article-title":"Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin","volume":"131","author":"Bovenschen","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cyto.2015.02.002_b0595","doi-asserted-by":"crossref","first-page":"e64531","DOI":"10.1371\/journal.pone.0064531","article-title":"Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS ONE"},{"issue":"1526\u201335","key":"10.1016\/j.cyto.2015.02.002_b0600","first-page":"e6","article-title":"Inhibition of interleukin-17 promotes differentiation of CD25(\u2212) cells into stable T regulatory cells in patients with autoimmune hepatitis","volume":"142","author":"Longhi","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2015.02.002_b0605","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1097\/MIB.0b013e3182a85709","article-title":"Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients","volume":"19","author":"Ueno","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cyto.2015.02.002_b0610","article-title":"Regulatory T cells in rheumatoid arthritis showed increased plasticity toward Th17 but retained suppressive function in peripheral blood","author":"Wang","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2015.02.002_b0615","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","article-title":"Molecular antagonism and plasticity of regulatory and inflammatory T cell programs","volume":"29","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2015.02.002_b0620","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.4049\/jimmunol.1003715","article-title":"TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function","volume":"187","author":"Nyirenda","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0625","doi-asserted-by":"crossref","first-page":"52ra72","DOI":"10.1126\/scitranslmed.3001107","article-title":"Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis","volume":"2","author":"Hueber","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cyto.2015.02.002_b0630","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/annrheumdis-2012-201601","article-title":"Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study","volume":"72","author":"Genovese","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2015.02.002_b0635","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/art.38617","article-title":"A phase II randomized study of subcutaneous ixekizumab, an anti-interleukin-17 monoclonal antibody, in rheumatoid arthritis patients who were naive to biologic agents or had an inadequate response to tumor necrosis factor inhibitors","volume":"66","author":"Genovese","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.cyto.2015.02.002_b0640","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/art.27334","article-title":"LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study","volume":"62","author":"Genovese","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2015.02.002_b0645","doi-asserted-by":"crossref","first-page":"R164","DOI":"10.1186\/ar4347","article-title":"A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis","volume":"15","author":"Martin","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"Suppl 5","key":"10.1016\/j.cyto.2015.02.002_b0650","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kes111","article-title":"Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugs","volume":"51","author":"Pavelka","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2015.02.002_b0655","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/eji.201242740","article-title":"Small molecule inhibitors of RORgammat: targeting Th17 cells and other applications","volume":"42","author":"Huh","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0660","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.immuni.2014.04.004","article-title":"Small-molecule RORgammat antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms","volume":"40","author":"Xiao","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2015.02.002_b0665","first-page":"905","article-title":"Ustekinumab treatment for psoriasis in 119 patients maintained on therapy for a minimum of one year: a review","volume":"13","author":"Wilder","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.cyto.2015.02.002_b0670","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s10067-012-2080-7","article-title":"Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis","volume":"31","author":"Song","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cyto.2015.02.002_b0675","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1756-185X.2011.01684.x","article-title":"Supplementation of 1,25 dihydroxy vitamin D3 in patients with treatment naive early rheumatoid arthritis: a randomised controlled trial","volume":"14","author":"Gopinath","year":"2011","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.cyto.2015.02.002_b0680","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/art.25043","article-title":"1,25-Dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis","volume":"62","author":"Colin","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2015.02.002_b0685","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1136\/annrheumdis-2011-201024","article-title":"Incomplete response of inflammatory arthritis to TNFalpha blockade is associated with the Th17 pathway","volume":"71","author":"Alzabin","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2015.02.002_b0690","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/rheumatology\/keq224","article-title":"Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression","volume":"49","author":"Aerts","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2015.02.002_b0695","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.4049\/jimmunol.1000906","article-title":"Nonsteroidal anti-inflammatory drugs increase TNF production in rheumatoid synovial membrane cultures and whole blood","volume":"185","author":"Page","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0700","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/blood-2010-06-293027","article-title":"Epigenetic modification of the human CCR6 gene is associated with stable CCR6 expression in T cells","volume":"117","author":"Steinfelder","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.02.002_b0705","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3899\/jrheum.130637","article-title":"One-year efficacy and safety results of secukinumab in patients with rheumatoid arthritis: phase II, dose-finding, double-blind, randomized, placebo-controlled study","volume":"41","author":"Genovese","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2015.02.002_b0710","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/annrheumdis-2013-204788","article-title":"Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial","volume":"73","author":"de Jong","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2015.02.002_b0715","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s11926-013-0372-9","article-title":"Epigenetics in rheumatoid arthritis: a primer for rheumatologists","volume":"15","author":"Bottini","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.cyto.2015.02.002_b0720","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nri3494","article-title":"MicroRNA-mediated regulation of T helper cell differentiation and plasticity","volume":"13","author":"Baumjohann","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0725","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/ni.2712","article-title":"Expression and regulation of intergenic long noncoding RNAs during T cell development and differentiation","volume":"14","author":"Hu","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0730","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ni.1962","article-title":"The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling","volume":"12","author":"Spits","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0735","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells \u2013 a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0740","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/eji.201242569","article-title":"IL-17-producing gammadelta T cells and innate lymphoid cells","volume":"42","author":"Sutton","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2015.02.002_b0745","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/ar4232","article-title":"Natural killer cells in human autoimmune disorders","volume":"15","author":"Fogel","year":"2013","journal-title":"Arthritis Res Ther"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615000575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615000575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T09:11:09Z","timestamp":1691658669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466615000575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":149,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1043466615000575"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2015.02.002","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2015.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}